Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 9 521 / https://doi.org/10.3332/ecancer.2015.521

Clinical Study

Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent

Itraconazole, a common triazole anti-fungal drug in widespread clinical use, has evidence of clinical activity that is of interest in oncology. There is evidence that at the clinically relevant doses, itraconazole has potent anti-angiogenic activity, and that it can inhibit the Hedgehog signalling pathway and may also induce autophagic growth arrest. The evidence for these anticancer effects, in vitro, in vivo, and clinical are summarised, and the putative mechanisms of their action outlined. Clinical trials have shown that patients with prostate, lung, and basal cell carcinoma have benefited from treatment with itraconazole, and there are additional reports of activity in leukaemia, ovarian, breast, and pancreatic cancers. Given the evidence presented, a case is made that itraconazole warrants further clinical investigation as an anti-cancer agent. Additionally, based on the properties summarised previously, it is proposed that itraconazole may synergise with a range of other drugs to enhance the anti-cancer effect, and some of these possible combinations are presented in the supplementary materials accompanying this paper.

Keywords: Drug repurposing, itraconazole, Hedgehog pathway inhibition, ReDO project

Loading Article Metrics ... Please wait

Related articles

Special Issue: Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab

Abstract | Full Article | PDF | Spanish Published: 22 Jan 2019 / https://doi.org/10.3332/ecancer.2019.898

Special Issue: Barriers in Latin America for the management of locally advanced breast cancer

Abstract | Full Article | PDF | Spanish Published: 22 Jan 2019 / https://doi.org/10.3332/ecancer.2019.897

Special Issue: Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America

Abstract | Full Article | PDF | Spanish Published: 22 Jan 2019 / https://doi.org/10.3332/ecancer.2019.896

Special Issue: Locally advanced breast cancer in Brazil: current status and future perspectives

Abstract | Full Article | PDF | Spanish Published: 22 Jan 2019 / https://doi.org/10.3332/ecancer.2019.895

Special Issue: Locally advanced breast cancer in young women in Latin America

Abstract | Full Article | PDF | Spanish Published: 22 Jan 2019 / https://doi.org/10.3332/ecancer.2019.894



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation